FREE Equity Delivery and MF
Flat ₹20/trade Intra-day/F&O
|
Buyback Record Date | |
Buyback Open Date | July 15, 2022 |
Buyback Closing Date | January 14, 2023 |
Issue Size (Amount) | ₹60.00 Crores |
Buyback Price | ₹60 per Share |
June 28, 2024 3:30:00 AM
Mumbai-based drug maker Marksans Pharma Ltd on Tuesday said its US subsidiary has bought 100% stake in New York-based Time-Cap Laboratories Inc. Financial details of the deal were not disclosed.
Published by : MintJuly 24, 2024 7:39:00 AM
Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all ...
Published by : InvestingJuly 18, 2024 7:28:00 PM
Marksans Pharma Ltd share price was up by 0.86% from the previous closing price of ?187.59. Who are peers of Marksans Pharma Ltd? The peers of Marksans Pharma Ltd are Sun Pharmaceuticals ...
Published by : Business TodayJuly 18, 2024 8:19:20 AM
Aurobindo Pharma on July 18 announced that share buyback worth up to Rs 750 crore at Rs 1,460 per share. "The Board approved buyback of up to 51.36 lakh fully paid-up equity shares of the Company, ...
Published by : Moneycontrol on MSNJuly 15, 2024 11:04:01 AM
Aurobindo Pharma shares zoomed over 6 percent to a fresh record high of Rs 1,409.9 on July 15 as investors lapped up the stock ahead of its board meeting to consider a buyback plan on July 18. If ...
Published by : Moneycontrol on MSNJuly 18, 2024 3:02:00 PM
On Tuesday, Hyderabad-based medicine company Aurobindo Pharma Ltd. announced its first ever buyback of equity shares valued up to ?750 Crore. Shares, however, have fallen since the news.
Published by : India InfolineJuly 22, 2024 3:30:00 AM
We sell different types of products and services to both investment professionals and individual investors. These products and services are usually sold through license agreements or subscriptions ...
Published by : MorningstarJuly 23, 2024 3:30:00 AM
The Price to Earnings (P/E) ratio, a key valuation measure, is calculated by dividing the stock's most recent closing price by the sum of the diluted earnings per share from continuing operations ...
Published by : Wall Street JournalNovember 7, 2017 8:57:00 PM
Marksans Pharma has received approval from the US health regulator for loratadine liquid filled capsules, used for treatment of allergies, in the American market. The company has been granted the ...
Published by : health.economictimes.indiatimesApril 22, 2024 7:53:00 PM
Learn about Marksans Pharma Ltd. in Verna, Goa.Find comprehensive contact details, including phone numbers and email addresses, and get directions to the location. If you own or are associated ...
Published by : MedindiaJuly 15, 2024 1:30:00 PM
Morningstar Quantitative Ratings for Stocks are generated using an algorithm that compares companies that are not under analyst coverage to peer companies that do receive analyst-driven ratings ...
Published by : MorningstarRead Marksans Pharma Buyback current news. Find Marksans Pharma Buyback subscription news, Buyback analysis, broker reviews, allotment news, and listing date. Get the Marksans Pharma Ltd Buyback grey market premium and Marksans Pharma Buyback expected listing price.
FREE Intraday Trading (Eq, F&O)
Flat ₹20 Per Trade in F&O
|